HyperVention

FROM: NNAMUDI MOKWUNYE, FOUNDER/CEO Welcome to HyperVention, the platform that personalizes drug schedules for hypertensive patients. "HyperVention" is a portmanteau of the words "hypertension" and "intervention". As 1 in 2 adult Americans is hypertensive, and hypertension remains the world's leading preventable cause of premature death, the disease likely affects you--or someone you know, or someone they know. HYPERVENTION IS PERSONAL My birth father died of a stroke in his sleep. He was hypertensive. Two years ago, I suffered a hypertensive crisis--meaning my blood pressure spiked and sustained at 222/121. If you, or someone you know, suffer from hypertension, you understand that, with those numbers, I am lucky to be alive--to have not suffered an aneurysm, stroke, or heart attack. However, I did suffer residual effects to my speech, balance, and overall electricals. They've gotten way better, but, for 18 months, I could not adequately execute the complex mental and physical functions I had done for over 20 years as a technology entrepreneur, strategy consultant, and fitness enthusiast. So, when my doctors prescribed my drugs to be taken at 9am and my blood pressure was still spiking at 11pm, I sensed that misaligned scheduling was the issue. So I took my blood pressure readings 30 times a day to generate enough data to identify spikes over daily 18 hours. Then I shifted my drug schedule to 9am, 3pm, and 9pm to cover 24 hours. Eventually, my blood pressure reduced to 114/73, leveled at 124/74, and just the other day was at 110/80. In hindsight, I realized I had created an effective system. While researching, I saw little done in the space of drug scheduling for hypertensive patients. So I patented my system and started a technology company to do for others what I had done for myself. THE PROBLEM The problem is that current, generic, drug scheduling methods do not target blood pressure spikes but expose hypertensive patients to severe outcomes such as aneurysms, strokes, heart attacks. We call these spikes "BP hotspots" and believe they can be muted and even eliminated. THE SOLUTION We are building HyperVention, a software platform that uses AI to personalize drug schedules for hypertensive patients. Our system is patent-pending and, if successful, we could move the needle in hypertension management, to the right, for the second time in 50 years. Join us in this journey! - tell your friends and family about HyperVention; - share this message with your network; - donate or invest, if you can; - write about why you think HyperVention could or could not work; - reach out if you'd like to work with or for us (we're hiring!) In the words of Tom Frieden (former CDC director), "Breakthrough drugs…are exciting, but the biggest health breakthrough of 2024 would be getting 100 million more people treated effectively for hypertension, the world’s leading killer." We're HyperVention. You're HyperVention. DONATE. INVEST. MOVE THE NEEDLE.